Cart
sales@molnova.com
Ganolucidic acid A
CAS No. 98665-21-5
Ganolucidic acid A( ——— )
Catalog No. M38479 CAS No. 98665-21-5
Ganolucidic acid A is a natural product that can be isolated from Ganoderma lucidum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 567 | Get Quote |
|
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGanolucidic acid A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGanolucidic acid A is a natural product that can be isolated from Ganoderma lucidum.
-
DescriptionGanolucidic acid A exhibits cytotoxicity, has inhibitory activities against human HeLa cervical cancer cell lines. It shows significant anti-human immunodeficiency virus (anti-HIV)-1 protease activity with IC50 values of 20-90 microM.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorHIV
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number98665-21-5
-
Formula Weight500.676
-
Molecular FormulaC30H44O6
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Min BS, et al. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull (Tokyo). 1998 Oct;46(10):1607-12.?
molnova catalog
related products
-
SLC26A3-IN-2
SLC26A3-IN-2 is an orally active compound that functions as an inhibitor of the anion exchanger protein SLC26A3, with an IC50 of 360 nM.
-
7-O-Methylaloeresin ...
7-O-Methylaloeresin A shows significant antioxidant activity, it also has moderate inhibitory active on BACE.
-
TGFβRI-IN-3
TGFβRI-IN-3 is a highly selective TGFβR1 inhibitor with an IC50 of 0.79 nM and exhibits 2000-fold selectivity against MAP4K4, showing potential applications in immuno-oncology .
